Delivery Order SPE2DB20D1004-SPE2DB23FF1U8

Award Date 2/6/23
Potential Completion Date 2/7/23
Potential Value $2.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,103.31 firm-fixed-price delivery order is for TRUVADA 200 MG-300 MG TABLET UU 30S, a pharmaceutical product, with a completion date of January 24, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,973.68 Firm Fixed Price Delivery Order contract is for the supply of TRUVADA 200 MG-300 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,508.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order (contract type: Firm Fixed Price) for the supply of TRUVADA 200 MG-300 MG TABLET (National Stock Number: 4563872551) to support military and veteran healthcare programs. The contract has an ultimate completion date of March 7, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,372.55 firm-fixed-price delivery order is for the supply of TRUVADA 200 mg-300 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which serves as a primary vehicle for the company to provide a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,745.21 for the supply of TRUVADA 100 MG-150 MG TABLET. The contract has no set-aside designation, indicating open competition. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Cencora, Inc. and the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,485.94 for the supply of pharmaceutical products, specifically TRUVADA 200-300MG 30S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,292.52 firm fixed-price delivery order is for the supply of TRUVADA 200 MG-300 MG tablets. The contract has an ultimate completion date of March 4, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (SPE2DX24F6C1F) with a ceiling value of $1,019.65. The contract is for the supply of TRUVADA 200 MG-300 MG TABLET UU 30S and is placed by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has a period of performance through February 26, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $34,131.59 Firm Fixed Price delivery order is for the supply of Truvada 200 mg-300 mg tablets. The award has an ultimate completion date of December 1, 2023 and was issued on November 30, 2022. Amerisourcebergen Drug Corp is an established pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and Department of...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $73,349.21, is for the delivery of Truvada 200 mg-300 mg tablets. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FF1U8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,943.12 firm-fixed-price delivery order is for the supply of TRUVADA 200 MG-300 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2023.

Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's healthcare needs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

In addition to the DLA contract, Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These large-scale IDCs demonstrate Amerisourcebergen's critical role as a key pharmaceutical distributor and solutions provider for multiple federal government agencies.

Generated 2/27/25, 11:44 AM